All lobbying filings

IPOLICY SOLUTIONS

Lobbying for ASSOCIATION FOR MOLECULAR PATHOLOGY · A medical subspecialty professional society

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $70,500.00 income · posted Jul 16, 2025

Official filing document

Bills named in this filing 5

HR 1463
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administrat…
HR 3152
Patent Eligibility Restoration Act of 2025
S 1546
Patent Eligibility Restoration Act of 2025
HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
SJRES 82
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule …

Lobbying activity 4

Medical/Disease Research/Clinical Labs

No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act

H.R.3152/S.1546: Patent Eligibility Restoration Act

Budget/Appropriations

H.R.4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Medicare/Medicaid

CMS Deregulation RFI: prior authorization, NCCI manual inconsistencies, CLFS payment reform

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.